These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23530639)

  • 1. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
    Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
    Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
    Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
    Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
    Bågeman E; Ingvar C; Rose C; Jernström H
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):895-901. PubMed ID: 18398030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
    Simonsson M; Söderlind V; Henningson M; Hjertberg M; Rose C; Ingvar C; Jernström H
    Cancer Causes Control; 2013 May; 24(5):929-40. PubMed ID: 23412805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden.
    Oh JK; Sandin S; Ström P; Löf M; Adami HO; Weiderpass E
    Int J Cancer; 2015 Oct; 137(8):1979-89. PubMed ID: 25885188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies.
    Jiang W; Wu Y; Jiang X
    Gynecol Oncol; 2013 Jun; 129(3):620-9. PubMed ID: 23535278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
    Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
    Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up.
    Ganmaa D; Willett WC; Li TY; Feskanich D; van Dam RM; Lopez-Garcia E; Hunter DJ; Holmes MD
    Int J Cancer; 2008 May; 122(9):2071-6. PubMed ID: 18183588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
    Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
    Cotterchio M; Mirea L; Ozcelik H; Kreiger N
    Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coffee, CYP1A2 genotype, and risk of myocardial infarction.
    Cornelis MC; El-Sohemy A; Kabagambe EK; Campos H
    JAMA; 2006 Mar; 295(10):1135-41. PubMed ID: 16522833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
    Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
    Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
    Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
    Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.
    Hong CC; Tang BK; Hammond GL; Tritchler D; Yaffe M; Boyd NF
    Breast Cancer Res; 2004; 6(4):R352-65. PubMed ID: 15217502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study.
    Le Marchand L; Donlon T; Kolonel LN; Henderson BE; Wilkens LR
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1998-2003. PubMed ID: 16103451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels.
    Klug TL; Bågeman E; Ingvar C; Rose C; Jernström H
    Mol Genet Metab; 2006 Dec; 89(4):381-9. PubMed ID: 16978896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.